Role and management of extracorporeal life support after surgery of chronic thromboembolic pulmonary hypertension.
Extracorporeal membrane oxygenator (ECMO)
deep hypothermic arrest
pulmonary endarterectomy (PEA)
pulmonary hypertension (PH)
Journal
Annals of cardiothoracic surgery
ISSN: 2225-319X
Titre abrégé: Ann Cardiothorac Surg
Pays: China
ID NLM: 101605877
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
12
3
2019
pubmed:
12
3
2019
medline:
12
3
2019
Statut:
ppublish
Résumé
Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Reasons for institution of ECLS include respiratory failure, cardiac failure (or both respiratory and cardiac failure), bleeding, and reperfusion edema. This article reviews the experience of ECLS after PEA from the current literature, as well as our own institution's experience as a CTEPH multidisciplinary center. A literature review was conducted along with a retrospective chart review from 15 years of our PEA program. The literature demonstrates many different approaches are used for mechanically supporting patients who develop complications after PEA. Variations in approach stem from differing indications such as, respiratory failure rather than hemodynamic compromise (or vice versa), time of implantation (immediately in operating room or delayed after surgery) and many other causes. In our center, 12.3% (19/154) of patients need ECLS with extracorporeal membrane oxygenator (ECMO) after PEA procedure. Implantation was mainly in the operating room before or immediately after weaning from cardiopulmonary bypass and mostly peripheral cannulation was used. ECMO lasted an average of 11±8 days. And 52.6% (10 of 19 patients) of patients were weaned from ECLS and of this, 70% (7 of 10 patients) were discharged. In some cases of PEA, ECLS is needed post-operatively. Expert teams should consider this possibility pre-operatively based on predisposing characteristics. The need for ECMO shouldn't be "di per se" a contraindication to surgery but might be considered in the surgical risk estimation. The ideal setup is not fixed and depends on the center's practices as well as indication. Even though complications do occur with ECMO, in general, results are good, being a bridge to further recovery of pulmonary hypertension (PH) or also to transplantation.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Reasons for institution of ECLS include respiratory failure, cardiac failure (or both respiratory and cardiac failure), bleeding, and reperfusion edema. This article reviews the experience of ECLS after PEA from the current literature, as well as our own institution's experience as a CTEPH multidisciplinary center.
METHODS
METHODS
A literature review was conducted along with a retrospective chart review from 15 years of our PEA program.
RESULTS
RESULTS
The literature demonstrates many different approaches are used for mechanically supporting patients who develop complications after PEA. Variations in approach stem from differing indications such as, respiratory failure rather than hemodynamic compromise (or vice versa), time of implantation (immediately in operating room or delayed after surgery) and many other causes. In our center, 12.3% (19/154) of patients need ECLS with extracorporeal membrane oxygenator (ECMO) after PEA procedure. Implantation was mainly in the operating room before or immediately after weaning from cardiopulmonary bypass and mostly peripheral cannulation was used. ECMO lasted an average of 11±8 days. And 52.6% (10 of 19 patients) of patients were weaned from ECLS and of this, 70% (7 of 10 patients) were discharged.
CONCLUSIONS
CONCLUSIONS
In some cases of PEA, ECLS is needed post-operatively. Expert teams should consider this possibility pre-operatively based on predisposing characteristics. The need for ECMO shouldn't be "di per se" a contraindication to surgery but might be considered in the surgical risk estimation. The ideal setup is not fixed and depends on the center's practices as well as indication. Even though complications do occur with ECMO, in general, results are good, being a bridge to further recovery of pulmonary hypertension (PH) or also to transplantation.
Identifiants
pubmed: 30854316
doi: 10.21037/acs.2019.01.02
pii: acs-08-01-84
pmc: PMC6379184
doi:
Types de publication
Journal Article
Langues
eng
Pagination
84-92Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Anesth Analg. 2004 Sep;99(3):672-5, table of contents
pubmed: 15333391
Ann Thorac Surg. 2006 Aug;82(2):630-6
pubmed: 16863777
Proc Am Thorac Soc. 2006 Sep;3(7):571-6
pubmed: 16963536
Ann Thorac Surg. 2006 Dec;82(6):2139-45
pubmed: 17126125
Eur J Cardiothorac Surg. 2008 Jul;34(1):159-63
pubmed: 18554921
Thorac Cardiovasc Surg. 2008 Sep;56(6):337-41
pubmed: 18704855
Ann Thorac Surg. 2008 Oct;86(4):1261-7
pubmed: 18805172
Intensive Care Med. 2012 Feb;38(2):210-20
pubmed: 22147116
J Thorac Cardiovasc Surg. 2013 May;145(5):1409-10
pubmed: 23312345
Eur Respir J. 2014 Dec;44(6):1401-3
pubmed: 25435525
J Heart Lung Transplant. 2016 Jan;35(1):67-73
pubmed: 26212656
Circulation. 2015 Aug 11;132(6):526-36
pubmed: 26260498
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Interact Cardiovasc Thorac Surg. 2016 Feb;22(2):181-7
pubmed: 26612405
Interact Cardiovasc Thorac Surg. 2016 Jul;23(1):74-8
pubmed: 27030685
Ann Thorac Surg. 2016 Jul;102(1):260-8
pubmed: 27112656
Int J Artif Organs. 2016 Jul 4;39(5):242-4
pubmed: 27229321
Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S201-6
pubmed: 27571001
Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):213-218
pubmed: 28289496
Eur Respir Rev. 2017 Mar 15;26(143):
pubmed: 28298388
Radiol Med. 2017 Jul;122(7):495-504
pubmed: 28316030
J Thorac Cardiovasc Surg. 2018 Feb;155(2):643-649
pubmed: 29033041
Eur Respir Rev. 2017 Dec 20;26(146):null
pubmed: 29263176
Crit Care. 2018 Jun 15;22(1):163
pubmed: 29907121